chr14-77378267-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001010860.4(SAMD15):āc.849G>Cā(p.Glu283Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000682 in 1,613,556 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001010860.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SAMD15 | NM_001010860.4 | c.849G>C | p.Glu283Asp | missense_variant | 1/3 | ENST00000216471.5 | NP_001010860.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SAMD15 | ENST00000216471.5 | c.849G>C | p.Glu283Asp | missense_variant | 1/3 | 2 | NM_001010860.4 | ENSP00000216471 | P1 | |
SAMD15 | ENST00000533095.2 | c.-70+1527G>C | intron_variant | 5 | ENSP00000450941 |
Frequencies
GnomAD3 genomes AF: 0.000355 AC: 54AN: 152166Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000840 AC: 21AN: 250084Hom.: 0 AF XY: 0.0000813 AC XY: 11AN XY: 135344
GnomAD4 exome AF: 0.0000383 AC: 56AN: 1461272Hom.: 0 Cov.: 38 AF XY: 0.0000275 AC XY: 20AN XY: 726972
GnomAD4 genome AF: 0.000355 AC: 54AN: 152284Hom.: 0 Cov.: 32 AF XY: 0.000336 AC XY: 25AN XY: 74454
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 31, 2022 | The c.849G>C (p.E283D) alteration is located in exon 1 (coding exon 1) of the SAMD15 gene. This alteration results from a G to C substitution at nucleotide position 849, causing the glutamic acid (E) at amino acid position 283 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at